ProQR Announces Third Quarter 2022 Operating and Financial Results Press release … ProQR Announces Third Quarter 2022 Operating and Financial Results Development of Axiomer ® RNA base editing … November 09, 2022
ProQR Announces Second Quarter 2022 Operating and Financial Results Press release … ProQR Announces Second Quarter 2022 Operating and Financial Results ProQR is accelerating the development of … August 04, 2022
ProQR Announces First Quarter 2022 Operating and Financial Results Press release … ProQR Announces First Quarter 2022 Operating and Financial Results Post-hoc analyses from Illuminate trial of … May 05, 2022
ProQR Announces Third Quarter 2020 Operating and Financial Results Press release … ProQR Announces Third Quarter 2020 Operating and Financial Results Illuminate Phase 2/3 trial of sepofarsen … November 16, 2020
ProQR Announces Fourth Quarter and Full Year 2020 Operating and Financial Results Press release … Announces Fourth Quarter and Full Year 2020 Operating and Financial Results Phase 2/3 pivotal Illuminate trial of … February 25, 2021
ProQR Announces First Quarter 2023 Operating and Financial Results Press release … ProQR Announces First Quarter 2023 Operating and Financial Results Initial pipeline programs with liver … May 16, 2023
ProQR Announces Second Quarter 2023 Operating and Financial Results Press release … ProQR Announces Second Quarter 2023 Operating and Financial Results Divestment of sepofarsen and ultevursen … August 03, 2023
ProQR Announces Second Quarter 2021 Operating and Financial Results Press release … ProQR Announces Second Quarter 2021 Operating and Financial Results Top-line data from Phase 2/3 pivotal … August 05, 2021
ProQR Announces First Quarter 2021 Operating and Financial Results Press release … ProQR Announces First Quarter 2021 Operating and Financial Results Phase 2/3 pivotal Illuminate trial of … May 06, 2021
ProQR Announces Third Quarter 2021 Operating and Financial Results Press release … ProQR Announces Third Quarter 2021 Operating and Financial Results Top-line data from pivotal Phase 2/3 … November 04, 2021